Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia.
Takami A, Ohtake S, Morishita E, Terasaki Y, Fukushima T, Kurokawa T, Sugimori N, Matano S, Ohata K, Saito C, Yamaguchi M, Hosokawa K, Yamazaki H, Kondo Y, Nakao S.
Takami A, et al. Among authors: morishita e.
Int J Hematol. 2012 Sep;96(3):357-63. doi: 10.1007/s12185-012-1155-1. Epub 2012 Aug 15.
Int J Hematol. 2012.
PMID: 22893108